These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22779708)

  • 1. Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris.
    Dhandha MM; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2012 Nov; 45(7):516-26. PubMed ID: 22779708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.
    Nagel A; Lang A; Engel D; Podstawa E; Hunzelmann N; de Pita O; Borradori L; Uter W; Hertl M
    Clin Immunol; 2010 Mar; 134(3):320-30. PubMed ID: 20015693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris.
    Naseer SY; Seiffert-Sinha K; Sinha AA
    Autoimmunity; 2015 Jun; 48(4):231-41. PubMed ID: 25384535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development?
    Torzecka JD; Woźniak K; Kowalewski C; Waszczykowska E; Sysa-Jedrzejowska A; Pas HH; Narbutt J
    Arch Dermatol Res; 2007 Aug; 299(5-6):239-43. PubMed ID: 17534636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
    Hacker MK; Janson M; Fairley JA; Lin MS
    Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris.
    Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA
    PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Hisata K; Iwatsuki K
    Br J Dermatol; 2012 Aug; 167(2):252-61. PubMed ID: 22404487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
    Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
    J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
    Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
    J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris.
    Green MG; Bystryn JC
    Arch Dermatol; 2008 Dec; 144(12):1621-4. PubMed ID: 19075146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
    Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
    Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
    J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
    Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
    Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype.
    Lebeau S; Müller R; Masouyé I; Hertl M; Borradori L
    Clin Exp Dermatol; 2010 Jun; 35(4):366-72. PubMed ID: 19874319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
    Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
    Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of an association between desmoglein 3 haplotypes and pemphigus vulgaris.
    Capon F; Bharkhada J; Cochrane NE; Mortimer NJ; Setterfield JF; Reynaert S; Black MM; Vaughan RW; Trembath RC; Harman KE
    Br J Dermatol; 2006 Jan; 154(1):67-71. PubMed ID: 16403096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.